160 related articles for article (PubMed ID: 35965535)
1. Karnofsky Performance Status (KPS) ≤60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain Metastases.
Freeman M; Ennis M; Jerzak KJ
Front Oncol; 2022; 12():867462. PubMed ID: 35965535
[TBL] [Abstract][Full Text] [Related]
2. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment clinical prognostic factors for brain metastases from breast cancer treated with Gamma Knife radiosurgery.
Roehrig AT; Ferrel EA; Benincosa DA; MacKay AR; Ling BC; Carlson JD; Demakas JJ; Wagner A; Lamoreaux WT; Fairbanks RK; Call JA; Cooke BS; Peressini B; Lee CM
Surg Neurol Int; 2016; 7(Suppl 35):S830-S836. PubMed ID: 27990315
[TBL] [Abstract][Full Text] [Related]
6. Treatment of five or more brain metastases with stereotactic radiosurgery.
Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
[TBL] [Abstract][Full Text] [Related]
7. Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis.
Depner JF; Berg T; Ejlertsen B; Andreasen LW; Møller S; Maraldo MV
Acta Oncol; 2023 Nov; 62(11):1502-1510. PubMed ID: 37750329
[TBL] [Abstract][Full Text] [Related]
8. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
9. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
10. Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single-Center Retrospective Study.
Gao YK; Kuksis M; Id Said B; Chehade R; Kiss A; Tran W; Sickandar F; Sahgal A; Warner E; Soliman H; Jerzak KJ
Oncologist; 2021 Nov; 26(11):e1951-e1961. PubMed ID: 34506676
[TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
12. The effect of whole-brain radiation (WBI) and Karnofsky performance status (KPS) on survival of patients receiving stereotactic radiosurgery (SRS) for second brain metastatic event.
Brown DR; Lanciano R; Heal C; Hanlon A; Yang J; Feng J; Stanley M; Buonocore R; Okpaku A; Ding W; Arrigo S; Lamond J; Brady L
J Radiat Oncol; 2017; 6(1):31-37. PubMed ID: 28367276
[TBL] [Abstract][Full Text] [Related]
13. Outcome after radiosurgery for brain metastases in patients with low Karnofsky performance scale (KPS) scores.
Chernov MF; Nakaya K; Izawa M; Hayashi M; Usuba Y; Kato K; Muragaki Y; Iseki H; Hori T; Takakura K
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1492-8. PubMed ID: 17276617
[TBL] [Abstract][Full Text] [Related]
14. Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer.
Id Said B; Soliman H; Moravan V; Myrehaug S; Tseng CL; Detsky J; Sahgal A; Warner E; Jerzak KJ
J Neurooncol; 2023 Sep; 164(2):437-445. PubMed ID: 37634217
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
18. Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery.
Wilson TG; Robinson T; MacFarlane C; Spencer T; Herbert C; Wade L; Reed H; Braybrooke JP
Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):390-396. PubMed ID: 32131980
[TBL] [Abstract][Full Text] [Related]
19. The role of whole brain radiation therapy in the management of melanoma brain metastases.
Dyer MA; Arvold ND; Chen YH; Pinnell NE; Mitin T; Lee EQ; Hodi FS; Ibrahim N; Weiss SE; Kelly PJ; Floyd SR; Mahadevan A; Alexander BM
Radiat Oncol; 2014 Jun; 9():143. PubMed ID: 24954062
[TBL] [Abstract][Full Text] [Related]
20. Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer.
Noteware L; Broadwater G; Dalal N; Alder L; Herndon Ii JE; Floyd S; Giles W; Van Swearingen AED; Anders CK; Sammons S
Breast Cancer Res Treat; 2023 Jan; 197(2):425-434. PubMed ID: 36403183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
